Angeli Andrea, Abdel-Aziz Alaa A-M, Nocentini Alessio, El-Azab Adel S, Gratteri Paola, Supuran Claudiu T
Università degli Studi di Firenze, NEUROFARBA Dept., Sezione di Scienze Farmaceutiche, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Florence, Italy.
Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia; Department of Medicinal Chemistry, Faculty of Pharmacy, University of Mansoura, Mansoura 35516, Egypt.
Bioorg Med Chem. 2017 Oct 15;25(20):5373-5379. doi: 10.1016/j.bmc.2017.07.056. Epub 2017 Jul 29.
A series of polycyclic imides was prepared by reaction of the benzenesulfonamide with an appropriate polycyclic acid anhydride in refluxing glacial acetic acid. The synthesized mono- and bis-sulfonamides were evaluated as a carbonic anhydrase inhibitors (CA, EC 4.2.1.1), more precisely against the human (h) isoforms hCA I, II, IX and XII, some of which are involved in various pathologies, such as glaucoma, epilepsy and cancer. Several low nanomolar and isoform-selective hCA II, IX and XII inhibitors were detected, and the structure-activity relationship for CA inhibition with this class of compounds is discussed in details. Computational studies allowed us to explain the efficacy and isoform-selective behaviour for some of these enzyme inhiibtors.
通过苯磺酰胺与适当的多环酸酐在回流的冰醋酸中反应制备了一系列多环酰亚胺。所合成的单磺酰胺和双磺酰胺被评估为碳酸酐酶抑制剂(CA,EC 4.2.1.1),更确切地说是针对人(h)同工型hCA I、II、IX和XII,其中一些与各种病理状况有关,如青光眼、癫痫和癌症。检测到了几种低纳摩尔且对同工型具有选择性的hCA II、IX和XII抑制剂,并详细讨论了这类化合物对CA抑制作用的构效关系。计算研究使我们能够解释其中一些酶抑制剂的功效和同工型选择性行为。